Asarfi Hospital
Close ·
- P/E
- 19.13
Key Fundamentals
SMEHealthcare ServicesHealthcarePrice-based figures at the close · EPS basis: Standalone · TTM
- ROCE
- 18.80%
- Debt to Equity
- 0.59
- EPS (TTM)
- ₹9.22
- Book Value
- ₹51.79
- Market Cap
- —
- P/E (TTM)
- 19.13
- P/B
- 3.41
- ROE
- 19.00%
- Dividend Yield
- 0.00%
- EBITDA
- ₹38.00 Cr
- 52W High
- ₹256.95
- 52W Low
- ₹135.00
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 74
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 49
- Average
- Cheap vs sector & own history 24% weight
- Growth
- 83
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 42
- Weak
- Solvency, leverage, coverage 9% weight
- Momentum
- 26
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 48
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company is expected to give good quarter
- Company has delivered good profit growth of 37.0% CAGR over last 5 years
Weaknesses
1- Though the company is reporting repeated profits, it is not paying out dividend
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 10 | 5 | 4 |
| Oscillators | Bearish | 3 | 5 | 1 |
| Moving Averages | Strong Bearish | 7 | 0 | 3 |
Oscillators
Bearish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 48.43
- Neutral
- MACD (12,26,9)
- −6.69
- Bearish
- SMA (50)
- 187.10
- Bearish
- SMA (200)
- 195.80
- Bearish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 5Y | +26.22% |
|---|---|
| 3Y | +35.85% |
| 1Y | +46.61% |
| TTM | +36.26% |
Net profit
| 5Y | +33.56% |
|---|---|
| 3Y | +28.56% |
| 1Y | +54.55% |
| TTM | +43.40% |
Operating cash flow
| 5Y | +13.70% |
|---|---|
| 3Y | +39.49% |
| 1Y | Turned positive |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | +6.00 pp |
|---|---|
| 3Y | +0.52 pp |
| 1Y | −0.38 pp |
| TTM | −0.47 pp |
Revenue by year
| Mar 2020 | ₹43.00 Cr |
|---|---|
| Mar 2021 | ₹54.00 Cr |
| Mar 2022 | ₹65.00 Cr |
| Mar 2023 | ₹69.00 Cr |
| Mar 2024 | ₹81.00 Cr |
| Mar 2025 | ₹118 Cr |
| Mar 2026 | ₹173 Cr |
Net profit by year
| Mar 2020 | ₹3.00 Cr |
|---|---|
| Mar 2021 | ₹4.00 Cr |
| Mar 2022 | ₹6.00 Cr |
| Mar 2023 | ₹8.00 Cr |
| Mar 2024 | ₹4.00 Cr |
| Mar 2025 | ₹11.00 Cr |
| Mar 2026 | ₹17.00 Cr |
Quarterly Results
₹ Cr| Particulars | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20.05 | 24.04 | 30.86 | 32.89 | 35.1 | 35.66 | 44.85 | 46.06 | 45.03 | 47.34 |
| Expenses | 16.04 | 20.05 | 24.06 | 25.9 | 28.64 | 28.63 | 35.94 | 35.95 | 37.17 | 37.92 |
| Operating Profit | 4.01 | 3.99 | 6.8 | 6.99 | 6.46 | 7.03 | 8.91 | 10.11 | 7.86 | 9.42 |
| OPM % | 20% | 16.6% | 22.03% | 21.25% | 18.4% | 19.71% | 19.87% | 21.95% | 17.46% | 19.9% |
| Other Income | 1.2 | −0.41 | 1.13 | 0.89 | 3.66 | 1.42 | 0.8 | 1.5 | 0.67 | 0.59 |
| Interest | 0.6 | 0.76 | 0.76 | 1.18 | 1.35 | 1.22 | 1.07 | 1.25 | 0.71 | 1.17 |
| Depreciation | 3.25 | 3.49 | 3.18 | 3.04 | 3.23 | 2.96 | 2.88 | 2.86 | 2.74 | 3.13 |
| PBT | 1.36 | −0.67 | 3.99 | 3.66 | 5.54 | 4.27 | 5.76 | 7.5 | 5.08 | 5.71 |
| Tax % | 102.94% | −76.12% | 27.07% | 25.41% | 30.87% | 25.29% | 25.17% | 27.07% | 19.49% | 25.22% |
| Net Profit | −0.05 | −0.16 | 2.9 | 2.72 | 3.83 | 3.2 | 4.3 | 5.48 | 4.09 | 4.27 |
| EPS (₹) | −0.03 | −0.08 | 1.47 | 1.38 | 1.95 | 1.63 | 2.19 | 2.78 | 2.08 | 2.17 |
Profit & Loss
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 43 | 54 | 65 | 69 | 81 | 118 | 173 | 183 |
| Expenses | 37 | 46 | 54 | 55 | 65 | 93 | 138 | 147 |
| Operating Profit | 6 | 8 | 11 | 14 | 16 | 25 | 36 | 36 |
| OPM % | 15% | 15% | 17% | 20% | 20% | 21% | 20% | 20% |
| Other Income | 0 | 0 | 1 | 2 | 2 | 6 | 3 | 4 |
| Interest | 1 | 1 | 1 | 1 | 3 | 4 | 4 | 4 |
| Depreciation | 2 | 3 | 3 | 4 | 9 | 13 | 11 | 12 |
| PBT | 4 | 5 | 8 | 11 | 6 | 15 | 23 | 24 |
| Tax % | 27% | 26% | 26% | 26% | 33% | 25% | 24% | — |
| Net Profit | 3 | 4 | 6 | 8 | 4 | 11 | 17 | 18 |
| EPS (₹) | 3.6 | 4.84 | 7.85 | 5.53 | 2.14 | 5.58 | 8.68 | 9.22 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 14 | 20 | 20 | 20 |
| Reserves | 12 | 16 | 21 | 27 | 51 | 62 | 79 |
| Borrowings | 5 | 7 | 12 | 17 | 32 | 49 | 58 |
| Other Liabilities | 9 | 13 | 28 | 34 | 52 | 34 | 38 |
| Total Liabilities | 28 | 37 | 63 | 93 | 154 | 164 | 194 |
| Fixed Assets | 18 | 22 | 31 | 39 | 94 | 101 | 108 |
| CWIP | 0 | 2 | 9 | 18 | 0 | 2 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 9 | 13 | 22 | 37 | 60 | 61 | 84 |
| Total Assets | 28 | 37 | 63 | 93 | 154 | 164 | 194 |
Cash Flow
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 2 | 10 | 9 | 7 | 26 | −4 | 19 |
| Investing | −5 | −16 | −23 | −21 | −63 | −8 | −19 |
| Financing | 2 | 6 | 14 | 15 | 36 | 13 | 5 |
| Net Cash Flow | 0 | 0 | 0 | 1 | −1 | 1 | 5 |
| Free Cash Flow | −5 | 2 | −10 | −13 | −20 | −14 | 1 |
| CFO/EBITDA | 62 | 142 | 104 | 73 | 162 | −3 | 69 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 20 | 14 | 30 | 90 | 109 | 123 | 114 |
| Inventory Days | 23 | 13 | 16 | 26 | 32 | 30 | 30 |
| Days Payable | 156 | 23 | 34 | 91 | 445 | 167 | 156 |
| Cash Conversion Cycle | −113 | 5 | 11 | 25 | −304 | −13 | −12 |
| Working Capital Days | −10 | −38 | −36 | 18 | 3 | 5 | 19 |
| ROCE % | — | 25% | 29% | 26% | 11% | 16% | 19% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Asarfi Hospital insights
60 extracted metrics across FY20–FY27.
Documents
- Q1 FY27 concall · Aug 2026PPT
- Q4 FY26 concall · May 2026Transcript PPT
- Q3 FY26 concall · Feb 2026PPT
- Q2 FY26 concall · Nov 2025Transcript PPT
- Q1 FY26 concall · Aug 2025PPT
- 7 Oct 2026
- 10 Oct 2025
- 26 Sep 2025
- 6 Sep 2024
- 16 May 2024
Frequently Asked Questions about Asarfi Hospital
What does Asarfi Hospital Ltd do?
Where is Asarfi Hospital Ltd (ASARFI) listed?
Which sector does Asarfi Hospital Ltd belong to?
What is the PE ratio of Asarfi Hospital Ltd?
What is the 52-week high and low of Asarfi Hospital Ltd?
What is the Return on Equity (ROE) of Asarfi Hospital Ltd?
Company Information
Incorporated in 2005, Asarfi Hospital Ltd provides primary health services & treatment and specialized super speciality health service
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543943.md for Asarfi Hospital Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.